· Market Analysis of Pharmaceutical Intermediates and Bulk Drugs

· Analysis of Drug Consumption in 10 Major Cities

· Import & Export of Bulk Pharmaceuticals During Jan-Sep

· Recent Applications for Administrative Protection

· Biological Products Approved by the Ministry of Health in the Second Half of 1997

· State Planning Commission Regulates Prices of Imported Drugs

· Sino-German Tianjin Hexal; · Lukang Reports US$100 Million In Output In Jan-Oct; · Huidefeng Shenlong Funded For Aminodarone Project; · Dongfeng Awarded For 6-APA Project; · Roche To Set Up Its 6th Joint Venture; · Reform of Pharmaceutical Companies Proved Successful; · Bayer To Invest In New Life Science Projects; · Fukang Group; · SB Constructs A US$100 Million Company; · East China Forms Large-Scale Pharm Group; · Novo Nordisk China R&D Center; · Yangtze Pharmaceutical Group; · Beijing Bailuyuan; · Antibioticos of Italy Operates Its Chinese Joint Venture; · Hangzhou Huadong Set Up Genetic Engineering Institute; · Injection Workshop Of Shijiazhuang No.1 Pharm Passed GMP Certification; · Novartis Strengthens China Presence; · North China Receives Government Special Supports; · Chifeng Pharmaceutical Group; · Haizheng Pharm To Be Listed Publicly; · Shenzhen Dazheng; · North China Acquires Taiyuan Pharm

· Anti-Osteoporosis New Drug; · Immunological Product – Thymopentin; · HCV & HGV Diagnostic Method; · Analgesic-Antipyretic Jiean Tablets; · Breakthrough In Cephalosporin Production – GCLH; · Two Bioengineering Products; · Roche Launches Albumin-Free Interferon; · Lentinan; · Esmolol Hydrochloride; · Domestic IFN a 2b Promising; · 11 TCM Products Approved By FDA; · Transgenic Lambs Produce Human Proinsulin; · Xiaokeling; · Five Bulk Drugs Sell Well; · Estradiol Controlled-Release Patches; · Bambuterol; · Simvastatin

· SPAC Requires Reducing Repeated Investment; · Drug Prices Cut In Hubei; · Drug Prices Drop 15% In Wuxi; · Shenzhen Launched Development Program For Medical Products; · Hunan Plans For Pharmaceutical Development; · Anhui Lowers Drug Retail Prices; · Zhejiang Pharm Industry Reports Double-Digit Growth In Jan-Oct; · China’s Finished TCM Sector Runs Well; · US Insurance Company Sponsors Investigation of Affluent Diseases; · Research On Hepatitis E; · Fujian Favors 10 Large-Scale Pharmaceutical Groups; · PhRMA President Visits China; · Shanghai Adjusts Retail Prices of 47 Medicines; · China South Biological Diagnosis & Treatment Center; · First Round of Hospital Rating; · First Share-holding Hospital Emerged In Henan; · A Share-holding Hospital Established In Haimen; · Experts Favors Domestically-Made Hepatitis A Vaccine; · Chinese Kids Need Vitamins; · State Plans To Promote TCM To The Outside World; · Erythromycin Producer Federation Formed; · Large Share-holding Hospital Emerged In Xi’an